Carnosic acid exhibits antiproliferative and proapoptotic effects in tumoral NCI-H460 and nontumoral IMR-90 lung cells

Amanda Cristina Corveloni,Simone Cristine Semprebon,Adrivanio Baranoski,Bruna Isabela Biazi,Thalita Alves Zanetti,Mário Sérgio Mantovani
DOI: https://doi.org/10.1080/15287394.2020.1767741
2020-05-27
Abstract:Carnosic acid (CA) is a phenolic diterpene with many important biological activities including antimicrobial, antioxidant, anti-inflammatory properties, and anti-proliferative properties. The aim of the present study was to investigate cytotoxic activity, cell cycle, apoptotic, and molecular effects attributed to CA in non-tumoral IMR-90 (human fetal lung fibroblasts), as well as tumoral NCI-H460 (human non–small-cell lung cancer) cell lines. Cell proliferation was evaluated by Real-Time Cell Analysis system, while apoptosis and cell cycle were assessed using flow cytometry. RT-qPCR was used to estimate the relative expression of genes involved in cell cycle regulation, DNA damage and repair, and apoptosis induction. CA inhibited proliferation of IMR-90 and NCI-H460 cells via cell cycle arrest at G<sub>0</sub>/G<sub>1</sub> and G<sub>2</sub>/M phases, according to the treatment concentration. The mRNA levels of genes encoding cyclins A2, B1, and B2 were downregulated in response to CA treatment of IMR-90 cells. Apoptosis was induced and proapoptotic gene <i>PUMA</i> was upregulated in both cell lines. mRNA levels of genes <i>ATR, CCND1, CHK1, CHK2, MYC, GADD45A, H2AFX, MTOR, TP53</i>, and <i>BCL2, CASP3</i> were not markedly changed following CA treatments. Although CA exerted antiproliferative activity against NCI-H460 tumor cells, this phytochemical induced toxic effects in non-tumoral cells, and thus needs to be considered carefully prior to pharmacological use therapeutically.
What problem does this paper attempt to address?